Frank C Detterbeck MD, FACS, FCCP

Professor of Surgery (Section of Thoracic Surgery); Chief, Thoracic Surgery; Surgical Director, Thoracic Oncology; Clinical Program Leader, Thoracic Oncology Program, Smilow Cancer Hospital

Departments & Organizations

Yale Medical Group

Office of Student ResearchCancer Center, Yale: Thoracic Oncology Program; Cancer Prevention and Control Center; Radiobiology & Radiotherapy; Sarcoma Oncology ProgramThoracic Oncology Program | Surgery: Thoracic Surgery

Research Interests

Cancer biology; Cancer imaging techniques; Prognostic markers of cancers; Multimodality (multiple therapies for) treatment of cancer; Evidence-based medicine more...


  • BS, University of Michigan/Ann Arbor, 1976
  • M.D., Northwestern University, 1983

Selected Publications

  • Anagnostou VK, Bepler G, Syrigos KN, Tanoue LT, Gettinger S, Homer RJ, Boffa D, Detterbeck FC, Rimm DL. High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer. J Clin Oncol 2009;15:4157-64
  • Detterbeck FC., Boffa D, Tanoue LT. The New Lung Cancer Staging System. Chest 2009;136:260-71
  • Detterbeck FC, Socinski MA, Gralla RJ, Edelman MJ, Jahan TM, Loesch DM, Limentani SA, Govindan R, Ye Z, Monberg M, Obasaju CK. Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC). J Thor Oncol 2008;3:37-45



Latest News


Edit Profile